HCM
HURA

Hodges Capital Management’s TuHURA Biosciences HURA Stock Holding History

Hodges Capital Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,000
Closed -$17.9K – 239
2026
Q1 		$17.9K Hold
10,000
– – ﹤0.01% 199
2025
Q4 		$7.57K Buy
+10,000
New +$19.1K ﹤0.01% 196

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Hodges Capital Management's HURA Position: Q2 2026 in Review

Hodges Capital Management sold out of TuHURA Biosciences (HURA) in Q2 2026, closing a stake of 10,000 shares — an estimated $17.9K sold.

Hodges Capital Management first reported a position in HURA in Q4 2025 and held it in 2 quarters. The position peaked at $17.9K in Q1 2026. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Hodges Capital Management reported no remaining TuHURA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Hodges Capital Management sold 10,000 TuHURA Biosciences shares in Q2 2026, an estimated $17.9K.
  • Hodges Capital Management first reported a position in TuHURA Biosciences in Q4 2025 and held it in 2 quarters.
  • Hodges Capital Management's TuHURA Biosciences position peaked at $17.9K in Q1 2026.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Hodges Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.